Received Apr 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3334Y | — |
Splash of prepared vaccine to the skin; This non-serious case was reported by a nurse via call center representative and described the occurrence of occupational exposure via skin contact with product in a 23-year-old female patient who received Herpes zoster (Shingrix) (batch number 3334Y, expiry date 25-MAR-2027) for prophylaxis. On 09-APR-2025, the patient received Shingrix. On 09-APR-2025, an unknown time after receiving Shingrix, the patient experienced occupational exposure via skin contact with product (Verbatim: Splash of prepared vaccine to the skin). The outcome of the occupational exposure via skin contact with product was not applicable. Additional Information: GSK Receipt Date: 09-APR-2025 The nurse reported that the skin exposure to the reconstituted Shingrix vaccine as when they had prepared the dose, a small amount splashed onto their skin. no vaccine was administered as per worded by the health care professional, but the health care professional expressed she was exposed to it because it splashed on her skin. The vaccine administration facility was the same as primary reporter.